Bioxytran Management
Management criteria checks 2/4
Bioxytran's CEO is David Platt, appointed in Sep 2018, has a tenure of 5.67 years. total yearly compensation is $420.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 36.08% of the company’s shares, worth $7.02M. The average tenure of the management team and the board of directors is 5.7 years and 2.8 years respectively.
Key information
David Platt
Chief executive officer
US$420.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 5.7yrs |
| CEO ownership | 36.1% |
| Management average tenure | 5.7yrs |
| Board average tenure | 2.8yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$4m |
| Dec 31 2023 | US$420k | US$420k | -US$4m |
| Sep 30 2023 | n/a | n/a | -US$4m |
| Jun 30 2023 | n/a | n/a | -US$3m |
| Mar 31 2023 | n/a | n/a | -US$2m |
| Dec 31 2022 | US$109k | US$109k | -US$2m |
| Sep 30 2022 | n/a | n/a | -US$3m |
| Jun 30 2022 | n/a | n/a | -US$3m |
| Mar 31 2022 | n/a | n/a | -US$3m |
| Dec 31 2021 | US$214k | US$214k | -US$4m |
| Sep 30 2021 | n/a | n/a | -US$4m |
| Jun 30 2021 | n/a | n/a | -US$4m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$72k | US$72k | -US$2m |
| Sep 30 2020 | n/a | n/a | -US$2m |
| Jun 30 2020 | n/a | n/a | -US$3m |
| Mar 31 2020 | n/a | n/a | -US$2m |
| Dec 31 2019 | US$72k | US$72k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$1m |
| Jun 30 2019 | n/a | n/a | -US$617k |
| Mar 31 2019 | n/a | n/a | -US$487k |
| Dec 31 2018 | US$18k | US$18k | -US$296k |
Compensation vs Market: David's total compensation ($USD420.00K) is below average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Platt (70 yo)
5.7yrs
Tenure
US$420,000
Compensation
Dr. David Platt, Ph.D. is Chairman of Board of Directors at Bioxytran, Inc. and has been serves as President, Chief Executive Officer and Director since September 21, 2018. Dr. Platt founded Boston Therape...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 5.7yrs | US$420.00k | 36.08% $ 7.0m | |
| CFO, Treasurer & Secretary | 5.7yrs | US$420.00k | 11.17% $ 2.2m | |
| Chief Communication Officer | 1.3yrs | US$280.00k | 4.57% $ 889.1k |
5.7yrs
Average Tenure
61yo
Average Age
Experienced Management: BIXT's management team is seasoned and experienced (5.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 5.7yrs | US$420.00k | 36.08% $ 7.0m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | no data | no data | 0.54% $ 104.0k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 2.8yrs | no data | 0.20% $ 38.7k | |
| Independent Director | no data | no data | 0.58% $ 112.2k | |
| Independent Director | no data | no data | 0.55% $ 106.2k | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
| CMO & Medical Advisory Board Chief | 1.3yrs | no data | no data | |
| Member of Medical Advisory Board | 1.3yrs | no data | no data | |
| Director | less than a year | no data | 0.057% $ 11.1k |
2.8yrs
Average Tenure
70yo
Average Age
Experienced Board: BIXT's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.